Atlas Trials

Immunogenicity and Safety of Hecolin® in HIV Positive/Negative Adults and in Children

Clinical trial NCT06306196 · RECRUITING

Trial details

NCT number
NCT06306196
Sponsor
International Vaccine Institute
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatitis E Virus Infection
Start date
2024-04-04
Primary completion
2026-01-01
Enrollment
1040

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.